Your browser doesn't support javascript.
loading
Anti-TNF certolizumab pegol induces antioxidant response in human monocytes via reverse signaling.
Boyer, Jean Frédéric; Baron, Michel; Constantin, Arnaud; Degboé, Yannick; Cantagrel, Alain; Davignon, Jean-Luc.
Affiliation
  • Boyer JF; Université Paul Sabatier Toulouse III, Toulouse, France. jeanfred.boyer@gmail.com.
  • Baron M; INSERM - CNRS U1043, CPTP, CHU Purpan, 1, Place Baylac, 31300, Toulouse, France. jeanfred.boyer@gmail.com.
  • Constantin A; Centre de Rhumatologie, Hopital Pierre Paul Riquet, Toulouse, France. jeanfred.boyer@gmail.com.
  • Degboé Y; Université Paul Sabatier Toulouse III, Toulouse, France. michel.baron@inserm.fr.
  • Cantagrel A; INSERM - CNRS U1043, CPTP, CHU Purpan, 1, Place Baylac, 31300, Toulouse, France. michel.baron@inserm.fr.
  • Davignon JL; Université Paul Sabatier Toulouse III, Toulouse, France. arnaud.constantin@univ-tlse3.fr.
Arthritis Res Ther ; 18: 56, 2016 Mar 01.
Article in En | MEDLINE | ID: mdl-26932562
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Monocytes / Signal Transduction / Reactive Oxygen Species / Antirheumatic Agents / Certolizumab Pegol Limits: Humans Language: En Journal: Arthritis Res Ther Journal subject: REUMATOLOGIA Year: 2016 Type: Article Affiliation country: France
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Monocytes / Signal Transduction / Reactive Oxygen Species / Antirheumatic Agents / Certolizumab Pegol Limits: Humans Language: En Journal: Arthritis Res Ther Journal subject: REUMATOLOGIA Year: 2016 Type: Article Affiliation country: France